Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Mexico Authorizes Hiv Injecting Treatment: How Does It Work?

Mexico City, Mexico.- A historic advance in the fight against the Human Immunodeficiency Virus (HIV) has arrived in Mexico: the Federal Commission for the Protection against Health Risks (Cofepris) has authorized long-acting antiretroviral injection therapy, marking a before and after in the care of people with the virus. This innovative therapeutic scheme, composed of cabotegravir and rilpivirine (CAB+RPV AP), represents the first injectable al…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

Punto y Coma MX This progress responds to the WHO recommendation to implement long-term preventive treatments. The Federal Commission for the Protection against Health Risks (Cofepris) announced in its July report that it granted a total of 210 health authorizations, including 164 for medical devices, 28 for medicines and 18 for clinical research protocols. Among these approvals is a historic step in public health: the authorization of cabotegra…

Read Full Article

Mexico approves revolutionary HIV medicine: one injection every two months Cabotegravir arrives to change the rules of the game in prevention jreyes Sat, 16/08/2025 - 10:17 The Federal Commission for the Protection against Health Risks (Cofepris) has just given the green light to cabotegravir, a long-acting injectable medicine that promises to become the best ally to prevent new HIV infections. It sounds like science fiction, but not: with only …

Read Full Article

Mexico City, Mexico.- A historic advance in the fight against the Human Immunodeficiency Virus (HIV) has arrived in Mexico: the Federal Commission for the Protection against Health Risks (Cofepris) has authorized long-acting antiretroviral injection therapy, marking a before and after in the care of people with the virus. This innovative therapeutic scheme, composed of cabotegravir and rilpivirine (CAB+RPV AP), represents the first injectable al…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Periódico Correo broke the news in on Friday, August 15, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal